Fig. 3: Overall survival after COVID-19 convalescent plasma transfusion.

Kaplan-Meier method was used according to  the type of hematological malignancy (A); the exposition to anti-CD20 or anti-CD19 monoclonal antibodies (mAbs) (B); and the COVID-19 severity (WHO scale) (C).